Use of severity scoring and stratification factors in clinical trials of Hospital-acquired and ventilator-associated pneumonia

Clinical Infectious Diseases

Volumn 51, Issue SUPPL. 1, 2010, Pages

  Napolitano, Lena M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EXTENDED SPECTRUM BETA LACTAMASE;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; APACHE; ARTIFICIAL VENTILATION; BACTERIAL GROWTH; CLINICAL PULMONARY INFECTION SCORE; CLINICAL TRIAL; COLONY FORMING UNIT; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIALYSIS; DISEASE SEVERITY; DRUG EFFICACY; ENTEROBACTER; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HOSPITAL ACQUIRED PNEUMONIA; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INTENSIVE CARE; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MULTIPLE ORGAN FAILURE; PATHOGENESIS; PNEUMONIA SPECIFIC SEVERITY INDEX; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEUS; RISK ASSESSMENT; SCORING SYSTEM; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIAL PNEUMONIA; CLINICAL TRIAL (TOPIC); CROSS INFECTION; HOSPITAL; MORTALITY; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

CLINICAL TRIALS AS TOPIC; CROSS INFECTION; HOSPITALS; HUMANS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; SEVERITY OF ILLNESS INDEX;

EID: 77955694881     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653052     Document Type: Conference Paper

References (62)

1. American Thoracic Society and the Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
2. Kollef MH, Morrow LE, Baughman RP, et al. Healthcare-associated pneumonia (HCAP): a critical appraisal to improve identification, management and outcomes. Proceedings of the HCAP Summit. Clin Infect Dis 2008; 46(Suppl 4):S296-S334.
3. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large U.S. database of culture-positive pneumonia. Chest 2005; 128(6):3854-3862.
4. Rello J, Diaz E. Pneumonia in the intensive care unit. Crit Care Med 2003; 31(10):2544-2551
5. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia cause by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539.
6. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336(4):243-250.
7. Ebell MH. Outpatient vs. inpatient treatment of community-acquired pneumonia. Fam Pract Manag 2006; 13(4):41-44.
8. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med 2005; 118(4):384-392.
9. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax 2009; 64(Suppl 3):1-55.
10. British Thoracic Society. http://www.brit-thoracic.org.uk/Portals/0/ Clinical-Information/Pneumonia/Guidelines/CAPGuideline-full.pdf. Accessed 29 December 2009.
11. Pugin JR, Auckenthaler N, Mili JP, et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Res-pir Dis 1991; 143:1121-1129.
12. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162(2Pt1):505-511.
13. Fartoukh M, Maitre B, Honore S, et al. Diagnosing pneumonia during mechanical ventilation: The clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003; 168:173-179.
14. Schurink CA, Van Nieuwenhoven CA, Jacobs JA, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: Accuracy and inter-observer variability. Intensive Care Med 2004; 30:217-224.
15. Lauzier F, Cook D, Heyland D, et al.; Canadian Critical Care Trials Group. The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. J Crit Care 2008; 23:50-57.
16. Croce MA, Swanson JM, Magnotti LJ, et al. The futility of the clinical pulmonary infection score in trauma patients. J Trauma 2006; 60: 523-528.
17. Pham TN, Neff MJ, Simmons JM, et al. The clinical pulmonary infection score poorly predicts pneumonia in patients with burns. J Burn Care Res 2007; 28:76-79.
18. National Nosocomial Infections Surveillance System. National Noso-comial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32(8):470-485
19. Edwards JR, Peterson KD, Andrus ML, et al; NHSN Facilities. National Healthcare Safety Network (NHSN Report, data summary for 2006, issued June 2007. Am J Infect Control 2007; 35(5):290-301.
20. Edwards JR, Peterson KD, Andrus ML, et al; NHSN Facilities. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 2008;36(9): 609-626. Erratum: Am J Infect Control 2009;37(5):425.
21. Rotstein C, Evans G, Born A, et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adult. Can J Infect Dis Med Microbiol 2008; 19(1):19-53.
22. Shorr AF, Cook D, Jiang X, et al; Canadian Critical Care Trials Group. Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. J Crit Care 2008; 23(1):64-73.
23. Wunderink RG, Rello J, Cammarata SK et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resis-tant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124(5): 1789-1797.
24. Kollef MH, Rello J, Cammarata SK, et al. Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med 2004; 30(3):388-394.
25. Hodina M, Hanquinet S, Cotting J, et al. Imaging of cavitary necrosis in complicated childhood pneumonia. Eur Radiol 2002; 12(2):391-396.
26. Katz DS, Leung AN. Radiology of pneumonia. Clin Chest Med 1999; 20(3):549-562.
27. Sharma S, Maycher B, Eschun G. Radiological imaging in pneumonia: recent innovations. Curr Opin Pulm Med 2007; 13(3):159-169.
28. Villar J, Domingo ML, Soto C, Cogollos J. Radiology of bacterial pneumonia. Eur J Radiol 2004;51(20):102-113.
29. Croce MA, Fabian TC, Waddle-Smith L, Maxwell RA. Identification of early predictors for post-traumatic pneumonia.AmSurg 2001; 67(2): 105-110.
30. Rea-Neto A, Youssef NC, Ruche F, et al. Diagnosis of ventilator- associated pneumonia: a systematic review of the literature. Crit Care 2008; 12(2):R56.
31. Mondi MM, Chang MC, Bowton DL, et al. Prospective comparison of bronchoalveolar lavage and quantitative deep tracheal aspirate in the diagnosis of ventilator-associated pneumonia. J Trauma 2005; 59(4):891-895.
32. Aarts MW, Hancock JN, Heyland D, et al. Empiric antibiotic therapy for suspected ventilator-associated pneumonia: a systematic review and meta-analysis of randomized trials. Crit Care Med 2008; 36(1):108-117.
33. Hedrick TL, Smith RL, McElearney ST, et al. Differences in early and late onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 2008; 64(3):714-720.
34. Linn S. The injury severity score\importance and uses. Ann Epidemiol 1995; 5(6):440-446.
35. Salottolo K, Settell A, Uribe P, et al. The impact of the AIS 2005 revision on injury severity scores and clinical outcome measures. Injury 2009; 40(9):999-1003.
36. Antonelli M, Moro ML, Capelli O, et al. Risk factors for early onset pneumonia in trauma patients. Chest 1994; 105(1):224-228.
37. Corwin HL, Gettinger A, Fabian TC, et al.; EPO Critical Care Trials Group. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007; 357(10):965-976.
38. Napolitano LM, Fabian TC, Kelly KM, et al. Improved survival of critically ill trauma patients treated with recombinant erythropoietin. J Trauma 2008; 65(2):285-297.
39. Takala J. Better conduct of clinical trials: the control group in critical care trials. Crit Care Med 2009; 37(1 Suppl):S80-S90.
40. Annane D. Improving clinical trials in the critically ill: unique challenge\sepsis. Crit Care Med 2009; 37(1 Suppl):S117-S128.
41. Strand K, Flaatten H. Severity scoring in the ICU: a review. Acta An-aesthesiol Scand 2008; 52(4):467-476.
42. Cook DA. Methods to assess performance of models estimating risk of death in intensive care patients: a review. Anaesth Intensive Care 2006; 34(2):164-175.
43. Afessa B, Gajic O, Keegan MT. Severity of illness and organ failure assessment in adult intensive care units. Crit Care Clin 2007; 23(3): 639-658.
44. Finfer S, Ranieri VM, Thompson BT et al. Design, conduct, analysis and reporting of a multinational placebo-controlled trial of activated protein C for persistent septic shock. Intensive Care Med 2008; 34(11): 1935-1947.
45. Kuzniewicz MW, Vasilevskis EE, Lane R, et al. Variation in ICU risk-adjusted mortality: impact of methods of assessment and potential confounders. Chest 2008; 133(6):1319-1327.
46. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2005; 73(4):503-508.
47. Kollef KE, Reichley RM, Micek ST, Kollef MH. The modified APACHE II score outperforms CURB65 pneumonia severity score as a predictor of 30-day mortality in patients with MRSA pneumonia. Chest 2008; 133(2):363-369.
48. Chastre J, Wunderink R, Prokocimer P, et al. Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: a multicenter, randomized study. Crit Care Med 2008; 36:1089-1096.
49. Chastre J, Wolff M, Fagon JY, et al: Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290:2588-2598.
50. Combes A, Luyt CE, Fagon Y, et al. Early predictors of infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007; 35(1):146-154.
51. Mayr VD, Dunser MW, Greil V, et al. Causes of death and determinants of outcome in critically ill patients. Crit Care 2006; 10(6):R154.
52. Vincent JL, Sakr Y, Sprung C, et al. For the Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006; 34(2):344-353.
53. Cook R, Cook D, Tilley J, Lee K, Marshall J; Canadian Critical Care Trials Group. Multiple organ dysfunction: baseline and serial component scores. Crit Care Med 2001; 29(11):2046-2050.
54. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996; 22:707-710.
55. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in ICUs: results of a multicenter, prospective study. Crit Care Med 1998; 26:1793-1800.
56. Levy MM, Fink MP, Marshall JC, et al; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31(4):1250-1256.
57. Rubulotta F, Marshall JC, Ramsay G, et al. Predisposition, insult/infection, response and organ dysfunction: a new model for staging severe sepsis. Crit Care Med 2009; 37(4):1329-1335.
58. Agbaht K, Diaz E, Munoz E, et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremia ventilator-associated pneumonia. Crit Care Med 2007; 35(9):2064-2070.
59. Combes A, Luyt CE, Fagon Y, et al. Early predictors of infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007; 35(1):146-154.
60. Lisboa T, Diaz E, Sa-Borges M, et al. The ventilator-associated pneumonia PIRO score: a tool for predicting ICU mortality and healthcare resource use in ventilator-associated pneumonia. Chest 2008; 134: 1208-1216.
61. Dominguez AA, Arango MV, Torres A. Treatment failure in patients with ventilator-associated pneumonia. Semin Respir Crit Care Med 2006; 27(1):104-114.
62. Depuydt PO, Vandijck DM, Bekaert MA, et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated pneumonia. Crit Care 2008; 12(6):R142.